Value Bridge — PROV SACRED HEART MEDICAL CENTER
Current $-47M → Target $-26M (+$20.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-47.3M
Current EBITDA
$-26.4M
Target EBITDA
+$20.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.7M
Payer Mix Optimization
$11.3M
Cost to Collect Reduction
$3.8M
Clean Claim Improvement
$2.8M
Volume & Rate Growth
$18.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-47M to $-26M. The highest-impact lever is Volume & Rate Growth at $7.6M probability-weighted.
IC talking point: "We see $21M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $230M in equity value creation."